194 related articles for article (PubMed ID: 34185313)
21. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
[TBL] [Abstract][Full Text] [Related]
22. Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic.
Haslak F; Yildiz M; Adrovic A; Sahin S; Koker O; Aliyeva A; Barut K; Kasapcopur O
Rheumatol Int; 2020 Sep; 40(9):1423-1431. PubMed ID: 32661928
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial.
Rahman M; Datta PK; Islam K; Haque M; Mahmud R; Mallik U; Hasan P; Haque M; Faruq I; Sharif M; Ratul RH; Azad KAK; Miah T; Rahman MM
PLoS One; 2022; 17(11):e0277790. PubMed ID: 36383611
[TBL] [Abstract][Full Text] [Related]
24. Colchicine, COVID-19 and hematological parameters: A meta-analysis.
Sarwar M; Ali Z; Fatima M; Sarfraz Z; Sarfraz A; Cherrez-Ojeda I
J Clin Lab Anal; 2021 Dec; 35(12):e24057. PubMed ID: 34708886
[TBL] [Abstract][Full Text] [Related]
25. Effect of increasing doses of colchicine on the treatment of 333 COVID-19 inpatients.
Tiholov R; Lilov AI; Georgieva G; Palaveev KR; Tashkov K; Mitev V
Immun Inflamm Dis; 2024 May; 12(5):e1273. PubMed ID: 38798123
[TBL] [Abstract][Full Text] [Related]
26. Repurposing Colchicine in Treating Patients with COVID-19: A Systematic Review and Meta-Analysis.
Lien CH; Lee MD; Weng SL; Lin CH; Liu LY; Tai YL; Lei WT; Liu JM; Huang YN; Chi H; Chiu NC; Lin CY
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440608
[TBL] [Abstract][Full Text] [Related]
27. Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients.
Montealegre-Gómez G; Garavito E; Gómez-López A; Rojas-Villarraga A; Parra-Medina R
Reumatol Clin (Engl Ed); 2021; 17(7):371-375. PubMed ID: 34301378
[TBL] [Abstract][Full Text] [Related]
28. Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials.
Lan SH; Hsu CK; Lai CC; Chang SP; Lu LC; Hung SH; Lin WT
Ann Med; 2022 Dec; 54(1):1956-1965. PubMed ID: 35833737
[TBL] [Abstract][Full Text] [Related]
29. Effects of Colchicine on Cardiovascular Outcomes in Patients with Coronary Artery Disease: A Systematic Review and One-Stage and Two-Stage Meta-Analysis of Randomized-Controlled Trials.
Teo YN; Teo YH; Syn NL; Goh MW; Yoong CSY; Lee CH; Chan MY; Chai P; Yeo TC; Sia CH
High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):343-354. PubMed ID: 34003455
[TBL] [Abstract][Full Text] [Related]
30. Remdesivir for the treatment of COVID-19.
Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
[TBL] [Abstract][Full Text] [Related]
31. The evidence from clinical trials on colchicine and corticosteroids' effect on COVID-19: a systematic review and meta-analysis.
Bitar AN; Sulaiman SAS
Curr Med Res Opin; 2022 Dec; 38(12):2097-2108. PubMed ID: 35819071
[TBL] [Abstract][Full Text] [Related]
32. Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Diaz R; Orlandini A; Castellana N; Caccavo A; Corral P; Corral G; Chacón C; Lamelas P; Botto F; Díaz ML; Domínguez JM; Pascual A; Rovito C; Galatte A; Scarafia F; Sued O; Gutierrez O; Jolly SS; Miró JM; Eikelboom J; Loeb M; Maggioni AP; Bhatt DL; Yusuf S;
JAMA Netw Open; 2021 Dec; 4(12):e2141328. PubMed ID: 34964849
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
Kim MS; An MH; Kim WJ; Hwang TH
PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357
[TBL] [Abstract][Full Text] [Related]
34. Colchicine in COVID-19: an Old Drug, New Use.
Schlesinger N; Firestein BL; Brunetti L
Curr Pharmacol Rep; 2020; 6(4):137-145. PubMed ID: 32837853
[TBL] [Abstract][Full Text] [Related]
35. Tocilizumab administration for the treatment of hospitalized patients with COVID-19: A systematic review and meta-analysis.
Kyriakopoulos C; Ntritsos G; Gogali A; Milionis H; Evangelou E; Kostikas K
Respirology; 2021 Nov; 26(11):1027-1040. PubMed ID: 34605114
[TBL] [Abstract][Full Text] [Related]
36. Impact of colchicine on mortality and morbidity in COVID-19: a systematic review.
Sanghavi D; Bansal P; Kaur IP; Mughal MS; Keshavamurthy C; Cusick A; Schram J; Yarrarapu SNS; Giri AR; Kaur N; Moreno Franco P; Abril A; Aslam F
Ann Med; 2022 Dec; 54(1):775-789. PubMed ID: 35258357
[TBL] [Abstract][Full Text] [Related]
37. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
Demidowich AP; Levine JA; Apps R; Cheung FK; Chen J; Fantoni G; ; Patel TP; Yanovski JA
Int J Obes (Lond); 2020 Aug; 44(8):1793-1799. PubMed ID: 32461554
[TBL] [Abstract][Full Text] [Related]
38. Oxygen Saturation in Hospitalized COVID-19 Patients and Its Relation to Colchicine Treatment: A Retrospective Cohort Study with an Updated Systematic Review.
Sharaf S; Ashmawy R; Saleh E; Salama M; El-Maradny YA; Zari A; Aly S; Tolba A; Mahrous D; Elsayed H; Latif D; Redwan EM; Kamal E
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241167
[No Abstract] [Full Text] [Related]
39. Risk factors for mortality in COVID-19 patients in sub-Saharan Africa: A systematic review and meta-analysis.
Bepouka B; Mayasi N; Mandina M; Longokolo M; Odio O; Mangala D; Mbula M; Kayembe JM; Situakibanza H
PLoS One; 2022; 17(10):e0276008. PubMed ID: 36251715
[TBL] [Abstract][Full Text] [Related]
40. Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial.
Rahhal A; Najim M; Aljundi AH; Mahfouz A; Alyafei SM; Awaisu A; Habib MB; Obeidat I; Faisal MM; Alanzi MA; Nair AP; Elhassan A; Al-Dushain A; Abdelmajid AA; Abdelgader AE; Moursi AMA; Alharafsheh AEN; Kamar MRA; Goravey W; Omar AS; Abukhattab M; Khatib MY; Mohamedali MG; AlMaslamani MAR; Alemadi S
Medicine (Baltimore); 2022 Sep; 101(39):e30618. PubMed ID: 36181009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
